rutin

Overview

Rutin is a naturally occurring flavonoid glycoside, widely distributed in plants and commonly discussed in biomedical research for its antioxidant, anti-inflammatory, anti-angiogenic, and broader cytoprotective properties. It is frequently identified in botanical and food matrices such as Sophora japonica, Fagopyrum esculentum (buckwheat), Morus alba leaves, citrus cultivars, pitaya peels, and other polyphenol-rich materials. In recent studies, rutin has been considered both as a bioactive constituent of complex extracts and as a standalone compound with potential therapeutic relevance.

Biologically, rutin is often investigated in relation to oxidative stress, inflammatory signaling, and disease pathways involving nuclear factor kappa B (NF-κB), TLR4, RUNX1, and related mediators. Across the provided studies, it was associated with antioxidant defense, modulation of proinflammatory cytokines, protection of the intestinal barrier, effects on metabolic dysfunction–associated steatotic liver disease, and antiangiogenic activity. It is also being explored in formulation strategies, including PEG-β-cyclodextrin and other delivery systems, to improve its in vivo performance.

Focus of Latest Publications

Recent investigations into rutin have focused on overcoming its therapeutic limitations and elucidating its molecular mechanisms of action across multiple disease contexts. Rutin, a natural flavonoid with documented antioxidant and anti-inflammatory properties, has demonstrated efficacy in treating conditions ranging from neurodegenerative diseases to chronic inflammatory disorders; however, its clinical application is hindered by extremely low water solubility and poor bioavailability. To address these constraints, multiple studies have developed advanced delivery systems, including polymer/lipid hybrid nanoparticles surface-engineered with glucosamine/chitosan blends, PEG-β-cyclodextrin polymer complexes, and nanoparticle conjugates, which have shown significantly enhanced bioavailability, controlled release profiles, and improved therapeutic effects compared to free rutin.

Mechanistic investigations have identified rutin as a direct binder of multiple intracellular targets, with studies demonstrating its ability to inhibit YANK2 kinase activity in glioblastoma (showing synergistic antitumor effects when combined with temozolomide), disrupt the RUNX1/TET2 complex to suppress TLR4/NF-κB signaling in non-alcoholic fatty liver disease, and target PD-L1 in atopic dermatitis. Network pharmacology analyses of rutin-containing herbal preparations have identified hub targets including MAPK8, SRC, IGF1, and HSP90AA1 in antioxidative stress pathways. In neuroinflammatory contexts, rutin has been incorporated into multifunctional delivery systems that simultaneously suppress amyloid-β aggregation and production while mitigating microglia and astrocyte activation, thereby reducing synapse loss and restoring cognitive function in Alzheimer's disease models.

Clinical and preclinical applications span diverse disease areas: in Henoch-Schönlein purpura, rutin ameliorated vascular injury and systemic inflammation through multiple mechanisms including restoration of intestinal barrier integrity via increased zonula occludens-1 and occludin expression, modulation of gut microbiota, and regulation of short-chain fatty acid metabolism. Rutin-containing natural products demonstrated synergistic pharmacological interactions with established therapeutics—for example, extracts enriched in rutin showed potentiated effects when combined with acarbose (α-glucosidase inhibition for diabetes) and donepezil (β-secretase inhibition for Alzheimer's disease). Antiangiogenic formulations of rutin have shown enhanced anticancer potential, while investigations into rutin's interactions with stress-response chaperones such as GRP78 suggest additional applications in cancer chemoresistance. Collectively, these studies establish rutin as a multitarget bioactive compound whose therapeutic potential is being substantially amplified through targeted delivery innovations and rational combination approaches.

Key Publications

• NEWJun MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma. (Molecular biomedicine, 2026, PMID 42337173): "Through structure based screening, rutin, a natural flavonoid compound, is identified as a potent direct binder of YANK2."
• NEWJun Glucosamine/chitosan blend surface-engineered rutin-loaded polymer/lipid hybrid nanoparticles for neuroprotection in induced schizophrenia model. (Scientific reports, 2026, PMID 42310329): "Behavioral, biochemical, and histopathological investigations demonstrated the therapeutic potential of rutin, which enhanced brain myelin basic protein (MBP) and neuregulin 1 (NRG1) levels, thereby restoring myelination."
• May Valorization of Pitaya (Selenicereus monacanthus) Peels: Proof of Concept for Food Formulation. (Plant foods for human nutrition (Dordrecht, Netherlands), 2026, PMID 42128980): "It showed a significant content of bioactive flavonoids, with isorhamnetin, rutin, myricetin, quercetin, and luteolin as major identified compounds."
• Jun Integrated UPLC-QTOF-MS and Network Pharmacology for Predicting Active Constituents and Pharmacological Mechanisms of Yinxingye Tablets Against Oxidative Stress. (Biomedical chromatography : BMC, 2026, PMID 42104588): "Bilobalide, pinoresinol diglucoside, rutin, kaempferol-3-O-rutinoside, together with certain organic acids and ginkgolides, were suggested to function as pivotal contributors to the antioxidant stress effects of Yinxingye tablets."
• May Therapeutic effect of rutin on Henoch-Schönlein purpura by attenuating inflammation and protection of the intestinal barrier function in rats. (European journal of pharmacology, 2026, PMID 42103052): "Rutin is a flavonoid with anti-inflammatory and antioxidant effects."
• May Nisin and rutin as potential coating agents for iron oxide nanoparticles for enhanced theranostic applications against cancer. (Scientific reports, 2026, PMID 42067522): "In this study, we explored the therapeutic potential of rutin and nisin conjugated IONPs as anticancer agents."
• May Study on the Protective Effect and Mechanism of Flos sophorae immaturus Extract and Its Main Active Ingredient Rutin on Meat Color. (Journal of agricultural and food chemistry, 2026, PMID 42047409): "The extract of Flos sophorae immaturus (FSI) and its main active ingredient rutin (52% of the FSI extract) show potential in preserving beef color."
• May Multi-omics reveals rutin directly targets RUNX1 to disrupt the RUNX1/TET2 complex and alleviate NAFLD via TLR4/NF-κB inhibition. (European journal of pharmacology, 2026, PMID 41997405): "Rutin, a bioactive flavonoid from Sophora japonica and Fagopyrum esculentum, possesses notable anti-inflammatory and antioxidant properties."
• Apr Evaluation of the underutilized Malpighia glabra L. fruits as a future functional food: nutritional composition, phenolic profile, biological activities, and synergistic effects with pharmaceutical drugs. (Food & function, 2026, PMID 41944642): "These activities were attributed to the phenolic composition, of which rutin was the predominant compound, as detected by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)."
• Jun Rutin targets PD-L1 for the treatment of atopic dermatitis: network pharmacological analysis and experimental evidence. (International immunopharmacology, 2026, PMID 41931959): "Rutin, a bioactive flavonoid abundant in traditional medicinal plants, has documented ethnomedical uses in inflammatory conditions and exhibits antioxidant, cytoprotective, and anti-inflammatory properties."